Skip to content
Wednesday 19 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,728.04
+0.07%
DAX
26,128.36
0.00%
CAC 40
8,509.36
0.00%
STOXX 50
6,468.17
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 29 December 2025 2:01 pm

PureHealth Introduces Pilot Phase of “Nada”, an AI-based Tool to Assist Doctors in Documenting Medical Notes During Patient Visits

PureHealth, the largest healthcare group in the Middle East, has announced the launch of the pilot phase of “Nada”, an AI-powered service that functions as a secure digital assistant, supporting physicians by capturing and organising clinical notes from medical conversations in real time. The pilot has been rolled out across selected PureHealth healthcare facilities as part of the Group’s efforts to enhance patient experience and improve the documentation and understanding of clinical information, through the deployment of advanced artificial intelligence technologies within a framework that prioritises patient privacy, data security, and compliance with relevant regulatory standards in the Emirate.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251229511888/en/

PureHealth introduces pilot phase of “Nada”, an AI-based tool to assist doctors in documenting medical notes during patient visits (Photo: AETOSWire)

Developed specifically for use during clinical consultations, “Nada” enables physicians to focus fully on patients’ needs, in line with a human-centred model of care that responds to even the most nuanced requirements. At the same time, the service reduces the need for manual notetaking and documentation during consultations, while ensuring that medical records remain accurate, comprehensive, and clinically reliable.

Shaista Asif, Group Chief Executive Officer of PureHealth, said: “Listening is the foundation of great healthcare. With ‘Nada’, we are strengthening the human connection at the heart of care by giving clinicians the freedom to truly engage with their patients. This is not about technology replacing human interaction, but about enabling it. By introducing ‘Nada’ across our local and global hospitals, we are enhancing the patient experience at scale and reinforcing our commitment to delivering care that is attentive, accurate and deeply human.”

The pilot phase of “Nada” follows a rigorous, multi-phase evaluation and testing process conducted across SEHA’s hospital network in the UAE. This included high-volume primary care settings, specialised services, and advanced, complex tertiary hospital environments.

The pilot phase will enable physicians and healthcare providers using “Nada” to reduce the time spent on clinical documentation by more than 50%, reclaiming an average of over two hours per clinician per day for direct patient care. The technology is also distinguished by its high levels of accuracy in capturing complex medical terminology and local dialects, supporting more precise clinical documentation and improving the quality and continuity of patients’ medical records.

For patients, the benefits are tangible and immediate. Consultations become more personal and less transactional, with doctors able to maintain eye contact, listen more closely and engage more meaningfully. Patients experience clearer communication, fewer repeated explanations and greater confidence that their concerns, symptoms and care plans are accurately reflected throughout their healthcare journey.

By integrating ambient AI that listens only within the clinical consultation and structures medical information instantly, PureHealth is moving beyond traditional digitisation towards a new era of cognitive healthcare, where technology operates quietly in the background to support people rather than replace them.

The name “Nada” carries particular resonance in Arabic, where it is associated with gentle presence, attentiveness and calm clarity. In a healthcare context, it reflects the principle of being truly heard, a value that sits at the heart of PureHealth’s approach to patient-centred care.

Through “Nada”, PureHealth is demonstrating how advanced artificial intelligence can be responsibly embedded into clinical practice to enhance patient experience, strengthen healthcare systems and deliver meaningful, long-term impact for communities.

Source: AETOSWire

PureHealth launches Nada AI tool to assist doctors with medical note documentation during patient visits at group hospitals.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251229511888/en/

Contact

Maroun Farah
Email: [email protected]

Abstract

PureHealth introduces pilot phase of “Nada”, an AI-based tool to assist doctors in documenting medical notes during patient visits

PureHealth introduces pilot phase of “Nada”, an AI-based tool to assist doctors in documenting medical notes during patient visits (Photo: AETOSWire)
Company Logo

PureHealth introduces pilot phase of “Nada”, an AI-based tool to assist doctors in documenting medical notes during patient visits (Photo: AETOSWire)

Company Logo

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Photo/Multimedia
  • Product/Service

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • Jobless Banquet: Youth unemployment surge ‘sends Neets to KFC’

  • US bond market jitters spark UK economy recession warning

  • Monzo chair makes early exit after boardroom rift

  • New Premier League rules could see £11bn invested into new stadiums

More from Morning Wire

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
  • NADclinic and GCLS Announce Strategic Collaboration in Longevity and Performance Medicine Education

    Business Wire
  • Clinigen Appoints Greg Skalicky as Chief Executive Officer

    Business Wire
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer

    Business Wire
  • Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

    Business Wire
  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook